A study of ExPD-101 for COPD with chronic bronchitis and frequent flare-ups
Part of Infections, Lungs & breathing clinical trials.
This study tests an experimental drug (ExPD-101) given daily as a pill for 52 weeks for people with COPD who have chronic bronchitis and frequent flare-ups. It compares the drug to a placebo (inactive pill) to see if it reduces flare-ups and improves symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD with chronic bronchitis (a daily cough with phlegm for at least 3 months in the last year).
- You have had at least 2 moderate or more than 1 severe COPD flare-up in the past year.
- You are using a dual- or triple-combination inhaler (like LABA/LAMA, ICS/LABA, ICS/LAMA, or a triple inhaler) every day for at least 3 months.
- You are a current or former smoker with at least a 10 pack-year history (1 pack a day for 10 years, for example).
- You have not had a COPD flare-up or pneumonia in the last month before starting the study.
- You do not have other lung diseases like asthma, active infection, or significant bronchiectasis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
This study tests an oral tablet called RSS0343 for people with moderate to severe COPD. It aims to see if the tablet can improve lung function and reduce flare-ups when added to your current breathing treatments.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.